$16.91
Today
as of Jul 22, 16:55 ET
Last 30 days
Recent Press Releases & News
TNDM: Raising target price to $16.00
Analyst Report: Tandem Diabetes Care, Inc.
Unpacking Q1 Earnings: Tandem Diabetes (NASDAQ:TNDM) In The Context Of Other Healthcare Technology Stocks
Overview
52-week range
$9.98
$30
35% of range
Avg surprise (last 3)
+1.0%
Avg reaction (last 2)
+1.5%
100% positive
Latest IV / EM
117%
EM ±26.8% · $17 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Thu May 7, 2026 | Mar/2026 | $-0.30 | $-0.46 | +34.8% | +55.2% | +2.4% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.31 | — | — | — | — | financials |
| Wed Aug 6, 2025 | Jun/2025 | $-0.48 | $-0.40 | -20.0% | — | — | earnings |
| Wed Apr 30, 2025 | Mar/2025 | $-0.67 | $-0.60 | -11.7% | — | +0.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.35 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.47 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-0.65 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-0.51 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-0.55 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Thu Aug 6, 2026 | Jun/2026 | AMC | -$0.34 | -$0.48 | +29.2% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $247M | — | $249M | $241M | $234M | — | $244M | $222M |
| Cost of revenue | $110M | — | $115M | $115M | $116M | — | $119M | $109M |
| Gross profit | $137M | — | $134M | $126M | $118M | — | $125M | $113M |
| Operating income | $-17M | — | $-23M | $-52M | $-121M | — | $-26M | $-31M |
| Net income | $-20M | — | $-21M | $-52M | $-131M | — | $-23M | $-31M |
| EPS (diluted) | $-0.30 | — | $-0.31 | $-0.78 | $-1.97 | — | $-0.35 | $-0.47 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $179M | $91M | $92M | $64M | $54M | $69M | $49M | $48M |
| Inventory | $126M | $129M | $137M | $143M | $141M | $150M | $152M | $162M |
| Total current assets | $887M | $618M | $617M | $615M | $663M | $724M | $753M | $733M |
| Total assets | $1.15B | $881M | $875M | $876M | $922M | $968M | $958M | $938M |
| Long-term debt | $602M | $310M | $310M | $309M | $309M | $308M | $308M | $307M |
| Total liabilities | $1.02B | $726M | $742M | $742M | $767M | $705M | $720M | $704M |
| Total equity | $132M | $155M | $133M | $133M | $155M | $263M | $238M | $234M |